Stem Cell Research (Mar 2023)

Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing

  • David Diouf,
  • Maria Rosaria Vitale,
  • Johanna Eva Maria Zöller,
  • Ana-Magdalena Pineau,
  • Eva Klopocki,
  • Catharina Hamann,
  • Georg Christoph Ziegler,
  • Tim Vanmierlo,
  • Daniel Van den Hove,
  • Klaus-Peter Lesch

Journal volume & issue
Vol. 67
p. 103038

Abstract

Read online

Fibroblasts isolated from a skin biopsy of a healthy individual were infected with Sendai virus containing the Yamanaka factors to produce transgene-free human induced pluripotent stem cells (iPSCs). CRISPR/Cas9 was used to generate an isogenic cell line carrying an inactivation of ST3GAL3, a risk gene associated with neurodevelopmental and psychiatric disorders. This ST3GAL3 null mutant (ST3GAL3-/-) iPSC line, which displays the expression of pluripotency-associated markers, the ability to differentiate into cells of the three germ layers in vitro, and a normal karyotype, is a powerful tool to investigate the impact of deficient sialylation of glycoproteins in neural development and plasticity.